BREAKING NEWS: The FDA has just approved a groundbreaking pill version of **Wegovy**, offering a **cheaper**, needle-free option for weight loss. This approval, announced by drugmaker **Novo Nordisk**, marks a significant development in weight management medications, making it more accessible for patients nationwide.
The new **once-daily oral Wegovy** pill will launch in the **U.S. in early January 2024**. The **starting price** is set at **$149 per month**, a sharp reduction compared to the **injectable version**, which costs around **$1,350** before insurance. This price drop is crucial as many users have reported struggling with affordability.
In a recent late-stage clinical trial involving **over 300 patients**, those taking the pill experienced an average weight loss of **16.6%** over approximately **64 weeks**, demonstrating results comparable to the injectable form. **Mike Doustdar**, CEO of Novo Nordisk, emphasized the convenience of the pill, stating, “With today’s approval of the Wegovy pill, patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy injection.”
The pill contains **semaglutide**, the same active ingredient as the injectable Wegovy, and is approved for adults with obesity or those who are overweight with at least one weight-related health condition. Furthermore, it aims to reduce the risk of serious cardiovascular events, such as heart attacks and strokes, for certain patients.
Demand for **GLP-1 weight-loss drugs** has skyrocketed, with the **KFF** health policy research group reporting that **12%** of adult Americans surveyed are currently using these medications, a rise of about **six percentage points** in just 18 months. However, the high costs have left many users grappling with affordability, as nearly **half** of respondents indicated they found it challenging to pay for these medications, even with insurance.
As the launch date approaches, Novo Nordisk plans to provide further details regarding coverage and savings options for higher doses and eligible patients. This development is expected to reshape the landscape of weight management, making effective treatment more attainable for countless individuals.
Stay tuned for updates as Wegovy’s pill hits the market and transforms the experience for those seeking weight loss solutions.
